SRG are delighted to be working with a highly exciting early stage biotechnology organisation who specialise in viral vector development and manufacture for use in the wider life sciences industry. Having recently received funding this company are
Senior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transformative medicines which address